Targeted therapy for cutaneous malignancies

Aleksandar Sekulic, Michael R. Migden, Anthony E. Oro, Luc Dirix, Karl D. Lewis, John D. Hainsworth, James A. Solomon, Simon Yoo, Sarah T. Arron, Philip A. Friedlander, Ellen Marmur, Charles M. Rudin, Anne Lynn S. Chang, Jennifer A. Low, Howard M. Mackey, Robert L. Yauch, Richard A. Graham, Josina C. Reddy, Axel Hauschild, Eve MaubecPeter Petrow, Isabelle Scheer-Senyarich, Pierre Duvillard, Ludovic Lacroix, Julien Gelly, Agnès Certain, Xavier Duval, Béatrice Crickx, Valérie Buffard, Nicole Basset-Seguin, Pierre Saez, Anne Duval-Modeste, Adamski Bénédicte, Mansard Henri, Grange Sandrine, Dompmartin Florent, Faivre Anne, Mentré Sandrine, Avril France, Marie Françoise, G. V. Long, A. Hauschild, M. Santinami, V. Atkinson, M. Mandal, V. Chiarion-Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, C. Robert, L. Mortier, J. Schachter, D. Schadendorf, T. Lesimple, R. Plummer, R. Ji, P. Zhang, B. Mookerjee, J. Legos, R. Kefford, R. Dummer, J. M. Kirkwood

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Targeted therapy holds great promise in advanced or metastatic cutaneous malignancies, although drugs can be expensive and have significant side effects. The following papers provide evidence for and describe outcomes and adverse effects of targeted therapy for these malignancies.

Original languageEnglish
Title of host publicationFoundational Papers in Oculoplastics
PublisherSpringer International Publishing
Number of pages12
ISBN (Electronic)9783030927943
ISBN (Print)9783030927936
StatePublished - 31 Jan 2022


  • Cutaneous malignancies
  • Eyelid cancer
  • Eyelid neoplasm
  • Skin cancer


Dive into the research topics of 'Targeted therapy for cutaneous malignancies'. Together they form a unique fingerprint.

Cite this